XML 55 R34.htm IDEA: XBRL DOCUMENT
v3.25.1

Shareholders’ Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Shareholders’ Equity [Abstract] |
Schedule of Significant Inputs into Black-Scholes Valuation Model | The significant inputs into the Black-Scholes valuation model at the initial recognition date are as follows:
|  | 5.5 Years June Warrants |  |  | 2 Years June Warrants |
Term |  |  | 5.5 years |  |  |  | 2 years |
Dividend |  |  | - |  |  |  | - |
Expected volatility |  |  | 44.77 | % |  |  | 44.77 | %
Risk-free rate |  |  | 3.95 | % |  |  | 4.28 | %
Stock price |  | $ | 1.97 |  |  | $ | 1.97 |
|  | 2 Years July Warrants |
Term |  |  | 2 years |
Dividend |  |  | - |
Expected volatility |  |  | 61.60 | %
Risk-free rate |  |  | 3.86 | %
Stock price |  | $ | 1.65 |
Schedule of Outstanding Warrants | Total outstanding warrants as of December 31,2024, are as follow:
|  | Number of warrants |  | Exercise price |  | Period left in years
Warrants May 2023 |  | 66,127 |  | $4.625 |  | 3.9
Warrants December 2023 |  | 1,360,170 |  | $1.18 - $1.47 |  | 4.5
Warrants June 2024 |  | 1,069,647 |  | $2 - $3.43 |  | 5.0
Warrants July 2024 |  | 2,069,317 |  | $2.5 - $1.75 |  | 1.75
Other |  | 36,792 |  | $10.27 - $50 |  | 1.50 - 2.4
Outstanding as of December 31, 2024 |  | 4,602,053 |  |  |  |
Schedule of Awards Granted | During the years ended December 31, 2024, and December 2023, the following awards were granted:
Award Type (2015 Plan) |  | Number of Awards in 2024 |  |  | Number of Awards in 2023 |  |  | Vesting Conditions |  | Expiration Date
Options |  |  | - |  |  |  | 400 |  |  | Over 4 years from grant date-25% every year (from the second year- 2.08% each month) |  | 10th anniversary of Grant Date
RSU |  |  | - |  |  |  | 45,100 |  |  | Over 3 years from grant date |  |
Schedule of Information Regarding Number of Ordinary Shares Issuable upon Outstanding Options and Exercisable Options | A summary of the Company’s share option activity under option plans is as follows:
|  | Number of Options |  |  | Weighted- Average Exercise Price |  |  | Weighted Average Remaining Contractual Life |
Outstanding – January 1, 2024 |  |  | 87,764 |  |  | $ | 3.63 |  |  |  | 4.11 |
Granted |  |  | - |  |  | $ | - |  |  |  | - |
Exercised |  |  | (22,809 | ) |  | $ | 0.96 |  |  |  | - |
Forfeited |  |  | (2,277 | ) |  | $ | 9.58 |  |  |  | - |
Outstanding – December 31, 2024 |  |  | 62,678 |  |  | $ | 4.38 |  |  |  | 3.4 |
Exercisable – December 31, 2024 |  |  | 59,721 |  |  | $ | 3.56 |  |  |  | 2.7 |
Schedule of Information Regarding Number of Ordinary Shares Issuable upon Outstanding Options and Exercisable Options | The following table summarize information as of December 31, 2024, regarding the number of ordinary shares issuable upon outstanding options and exercisable options:
Exercise price |  | Options outstanding as of December 31, 2024 |  |  | Weighted average remaining contractual life (years) |  |  | Options exercisable as of December 31, 2024 |  |  | Weighted average remaining contractual life (years) |
0.64 |  |  | 24,586 |  |  |  | 0.61 |  |  |  | 24,586 |  |  |  | 0.61 |
1.06 |  |  | 25,936 |  |  |  | 3.6 |  |  |  | 25,936 |  |  |  | 3.60 |
1.48 |  |  | 400 |  |  |  | 8.71 |  |  |  | 200 |  |  |  | 8.71 |
5.78 |  |  | 4,000 |  |  |  | 5.98 |  |  |  | 2500 |  |  |  | 4.79 |
13.62 |  |  | 3,894 |  |  |  | 6.41 |  |  |  | 3,830 |  |  |  | 6.41 |
40.00 |  |  | 3,862 |  |  |  | 7.69 |  |  |  | 2,669 |  |  |  | 7.67 |
|  |  | 62,678 |  |  |  |  |  |  |  | 59,721 |  |  |  |  |
The following table summarize information as of December 31, 2023, regarding the number of ordinary shares issuable upon outstanding options and exercisable options:
Exercise price |  | Options outstanding as of December 31, 2023 |  |  | Weighted average remaining contractual life (years) |  |  | Options exercisable as of December 31, 2023 |  |  | Weighted average remaining contractual life (years) |
0.64 |  |  | 30,309 |  |  |  | 1.61 |  |  |  | 30,309 |  |  |  | 1.61 |
1.06 |  |  | 43,461 |  |  |  | 4.44 |  |  |  | 43,402 |  |  |  | 4.43 |
1.48 |  |  | 400 |  |  |  | 9.71 |  |  |  | 100 |  |  |  | 9.71 |
5.78 |  |  | 5,500 |  |  |  | 8.96 |  |  |  | 1,750 |  |  |  | 8.96 |
13.62 |  |  | 3,894 |  |  |  | 7.41 |  |  |  | 2,524 |  |  |  | 7.41 |
40.00 |  |  | 4,200 |  |  |  | 8.72 |  |  |  | 1,979 |  |  |  | 8.72 |
|  |  | 87,764 |  |  |  |  |  |  |  | 80,064 |  |  |  |  |
Schedule of Share-based Compensation Expense for Share Options and RSUs | Share-based compensation expense for share options in the consolidated statements of comprehensive loss is summarized as follows:
|  | Year Ended December 31, |
|  | 2024 |  |  | 2023 |
Cost of revenues |  |  | 2 |  |  |  | 3 |
Research and development |  |  | 4 |  |  |  | 23 |
Sales and marketing |  |  | 2 |  |  |  | 11 |
General and administrative |  |  | 6 |  |  |  | 11 |
Total Share-based compensation expense |  |  | 14 |  |  |  | 48 |
Share-based compensation expense for RSUs in the consolidated statement of comprehensive loss is summarized as follows:
|  | Year Ended December 31 |
|  | 2024 |  |  | 2023 |
|  | U.S. dollars in thousands |
Cost of revenues |  |  | 10 |  |  |  | 9 |
Research and development |  |  | 18 |  |  |  | 53 |
Sales and marketing |  |  | 36 |  |  |  | 47 |
General and administrative |  |  | 259 |  |  |  | 220 |
Total Share-based compensation expense |  |  | 323 |  |  |  | 329 |
Schedule of Awards Granted | A summary of the Company’s RSUs activity under option plans is as follows:
|  | Year ended December 31, 2024 |
|  | Number of RSUs |  |  | Weighted- Average Grant Date Fair Value |
RSUs outstanding at the beginning of the year |  |  | 71,280 |  |  | $ | 10.35 |
Granted during the year |  |  | - |  |  |  |  |
Vested during the year |  |  | (28,228 | ) |  |  | 8.44 |
Forfeited during the year |  |  | (6,798 | ) |  |  | 7.44 |
Outstanding at the end of the year |  |  | 36,254 |  |  | $ | 12.38 |

X
- References No definition available. + Details
Name: | asns_ScheduleOfAwardsWereGrantedTableTextBlock
Namespace Prefix: | asns_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration